Research Paper Volume 16, Issue 2 pp 1696—1711

Therapeutic strategies and predictive models for Xp11.2 translocation/TFE3 gene fusion renal cell carcinoma in adults based on data of two Chinese medical centers


Figure 3. Calibration curve and ROC curve. Discrimination of the nomogram was evaluated by the ROC curve, AUC = 0.796 in the Ra cohort (A), AUC = 0.806 in the Ha cohort (B); calibration curves illuminate the agreement between the predicted risks of TFE3-RCC (C) and the observed incidence of TFE3-RCC (D). The dotted line represents the ideal flawless model.